These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 15143160)
41. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376 [TBL] [Abstract][Full Text] [Related]
42. ETV6: a versatile player in leukemogenesis. Bohlander SK Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831 [TBL] [Abstract][Full Text] [Related]
43. Cloning and characterization of mr-s, a novel SAM domain protein, predominantly expressed in retinal photoreceptor cells. Inoue T; Terada K; Furukawa A; Koike C; Tamaki Y; Araie M; Furukawa T BMC Dev Biol; 2006 Mar; 6():15. PubMed ID: 16539743 [TBL] [Abstract][Full Text] [Related]
44. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Stapleton D; Balan I; Pawson T; Sicheri F Nat Struct Biol; 1999 Jan; 6(1):44-9. PubMed ID: 9886291 [TBL] [Abstract][Full Text] [Related]
45. Vav transformation requires activation of multiple GTPases and regulation of gene expression. Palmby TR; Abe K; Karnoub AE; Der CJ Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759 [TBL] [Abstract][Full Text] [Related]
46. Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement. Panagopoulos I; Strömbeck B; Isaksson M; Heldrup J; Olofsson T; Johansson B Br J Haematol; 2006 May; 133(3):270-5. PubMed ID: 16643428 [TBL] [Abstract][Full Text] [Related]
47. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. Kim CA; Phillips ML; Kim W; Gingery M; Tran HH; Robinson MA; Faham S; Bowie JU EMBO J; 2001 Aug; 20(15):4173-82. PubMed ID: 11483520 [TBL] [Abstract][Full Text] [Related]
48. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways. Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521 [TBL] [Abstract][Full Text] [Related]
49. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816 [TBL] [Abstract][Full Text] [Related]
50. ETV6-NTRK3--Trk-ing the primary event in human secretory breast cancer. Euhus DM; Timmons CF; Tomlinson GE Cancer Cell; 2002 Nov; 2(5):347-8. PubMed ID: 12450787 [TBL] [Abstract][Full Text] [Related]
51. Stimulation of Oct-4 activity by Ewing's sarcoma protein. Lee J; Rhee BK; Bae GY; Han YM; Kim J Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470 [TBL] [Abstract][Full Text] [Related]
52. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner. I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919 [TBL] [Abstract][Full Text] [Related]
53. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability. Starczynowski DT; Reynolds JG; Gilmore TD Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730 [TBL] [Abstract][Full Text] [Related]
54. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro. Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925 [TBL] [Abstract][Full Text] [Related]
55. Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101. Nagasubramanian R; Wei J; Gordon P; Rastatter JC; Cox MC; Pappo A Pediatr Blood Cancer; 2016 Aug; 63(8):1468-70. PubMed ID: 27093299 [TBL] [Abstract][Full Text] [Related]
56. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells. Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341 [TBL] [Abstract][Full Text] [Related]
57. Gene expression of TrkC (NTRK3) in human soft tissue tumours. Hisaoka M; Sheng WQ; Tanaka A; Hashimoto H J Pathol; 2002 Aug; 197(5):661-7. PubMed ID: 12210087 [TBL] [Abstract][Full Text] [Related]
58. Biophysical characterization of the ETV6 PNT domain polymerization interfaces. Gerak CAN; Cho SY; Kolesnikov M; Okon M; Murphy MEP; Sessions RB; Roberge M; McIntosh LP J Biol Chem; 2021; 296():100284. PubMed ID: 33450226 [TBL] [Abstract][Full Text] [Related]
59. The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60. Putnik J; Zhang CD; Archangelo LF; Tizazu B; Bartels S; Kickstein M; Greif PA; Bohlander SK Biochim Biophys Acta; 2007 Dec; 1772(11-12):1211-24. PubMed ID: 17980166 [TBL] [Abstract][Full Text] [Related]
60. Dok-1 tyrosine residues at 336 and 340 are essential for the negative regulation of Ras-Erk signalling, but dispensable for rasGAP-binding. Shinohara H; Yasuda T; Yamanashi Y Genes Cells; 2004 Jun; 9(6):601-7. PubMed ID: 15189452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]